GlassScriptPhysician profile
Bernard J Park
NPI 1932184876
$138,356.37
in general payments reported to CMS, 2019-2025
17 companies · $5,547 in 2025
The $5,547 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $9,841 · 2021: $31K · 2022: $55K · 2023: $4,379 · 2024: $5,510 · 2025: $5,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,900 · Travel and Lodging: $4,027 · Food and Beverage: $2,510 · Education: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,900.00 |
| Travel and Lodging | $4,026.67 |
| Food and Beverage | $2,510.13 |
| Education | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $88,518.44 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $23,953.89 | 2022-2025 | Signia |
| Astrazeneca Pharmaceuticals LP | $12,135.09 | 2019-2022 | |
| Astrazeneca Uk Limited | $4,296.00 | 2021-2022 | |
| Medela LLC | $2,536.02 | 2025 | Vario, Dominant Flex |
| Davol INC. | $2,522.16 | 2019-2025 | Arista Ah Flexitip, Channel Drain |
| Regeneron Pharmaceuticals, INC. | $2,355.00 | 2021 | |
| Atricure, INC. | $988.63 | 2022 | |
| Becton, Dickinson and Company | $262.96 | 2024-2025 | Progel Applicator Spray Tips |
| Covidien LP | $208.73 | 2019 | |
| Amgen INC. | $130.83 | 2025 | Krystexxa |
| Merck Sharp & Dohme LLC | $124.93 | 2024 | Keytruda |
| Genentech USA, INC. | $117.04 | 2022 | |
| Novocure INC. | $96.42 | 2022 | |
| Medtronic Vascular, INC. | $82.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $27.97 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.